Zobrazeno 1 - 10
of 202
pro vyhledávání: '"giant-cell tumours"'
Publikováno v:
Bone & Joint Open, Vol 4, Iss 11, Pp 846-852 (2023)
Aims: Tenosynovial giant cell tumour (TGCT) is a rare benign tumour of the musculoskeletal system. Surgical management is fraught with challenges due to high recurrence rates. The aim of this study was to describe surgical treatment and evaluate surg
Externí odkaz:
https://doaj.org/article/add48e4165a44b3f82083226016a6e6c
Autor:
Hilwati Hashim, Nor Salmah Bakar
Publikováno v:
The Egyptian Journal of Radiology and Nuclear Medicine, Vol 51, Iss 1, Pp 1-5 (2020)
Abstract Background Giant cell tumours (GCT) are rare benign bone tumours that typically occur in the appendicular skeleton. In typical locations, these tumours are relatively simple to diagnose by radiography. However, at atypical locations, these t
Externí odkaz:
https://doaj.org/article/26071ecd2e374b61bad95a35898e9bfa
Autor:
N. N. Pavlenko, G. V. Korshunov, V. A. Muromtsev, L. A. Kesov, T. D. Maksyushina, O. V. Matveeva, S. G. Shakhmartova
Publikováno v:
Travmatologiâ i Ortopediâ Rossii, Vol 0, Iss 4, Pp 37-40 (2016)
The problems of timeliness and correctness of diagnostics of bone tumours, as well as therapeutic decision deserve the most careful consideration. The present research concerns the detection of criteria of differential diagnostics of giant-cell tumou
Externí odkaz:
https://doaj.org/article/119af4858aac4f9d90ab35fe2021ead2
Autor:
Kavinkumar, Singaravadivelu
Publikováno v:
Malaysian Orthopaedic Journal, Vol 14, Iss 3, Pp 42-49 (2020)
Malaysian Orthopaedic Journal
Malaysian Orthopaedic Journal
Introduction: Giant cell tumour (GCT) of the bone is a benign tumour with a high tendency to recur after surgery. This study aimed to analyse prospectively the rate of local recurrence following management of giant cell tumours by curettage, using in
Publikováno v:
EFORT Open Reviews
Diffuse-type tenosynovial giant-cell tumours of the knee (D-TGCT) have a very high complication rate. The recurrence rate for D-TGCT is mainly dependent on an initially successful resection of the lesion. The standard of care for this disease involve
Publikováno v:
The Bone & Joint Journal. :177-185
AimsTo investigate the benefits of denosumab in combination with nerve-sparing surgery for treatment of sacral giant cell tumours (GCTs).MethodsThis is a retrospective cohort study of patients with GCT who presented between January 2011 and July 2017
Publikováno v:
International Journal of Surgery Case Reports
Highlights • Giant cell tumours are locally aggressive with a relatively high recurrence rate. • Common sites are distal femur, proximal tibia and distal radius. • Contained lesions at these sites managed by joint preservation procedures such a
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 9, Iss 7, p RL01 (2015)
Externí odkaz:
https://doaj.org/article/d8e8254b39944e16812ecbf529a6a510
Autor:
Hasnaa Belgadir, Naima El Benna, Fatiha Aghrib, Aicha Merzem, El Mehdi Kabir, Omar Amriss, Nadia Moussali
Publikováno v:
European Journal of Case Reports in Internal Medicine (2021)
Eur J Case Rep Intern Med
Eur J Case Rep Intern Med
Giant cell tumours (GCT) are rare aggressive non-cancerous tumours which usually affect the long bones. We describe a case of GCT of the first rib in a young woman without a relevant history. The patient presented a left cervico-thoracic mass which w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec887bf011506c2dc2f54be2f24b53e8
https://www.ejcrim.com/index.php/EJCRIM/article/view/2329
https://www.ejcrim.com/index.php/EJCRIM/article/view/2329
Publikováno v:
The bonejoint journal. (10)
Aims There is a lack of evidence about the risk factors for local recurrence of a giant cell tumour (GCT) of the sacrum treated with nerve-sparing surgery, probably because of the rarity of the disease. This study aimed to answer two questions: first